April 2015
Volume 27, No. 4 |
|
|
|
|
|
Focus
L. Falce, A. Morreale, and C. Girani
The authors outline a validation approach for the manufacture of a "legacy product," taking into consideration recent guidelines. The aim is to demonstrate the validity and capacity of the manufacturing process following a change in the manufacturer.
/ read more /
|
|
Featured content
Jennifer Markarian
Quality-by-design tools improve efficiency in scale-up of pharmaceutical processes. / read more /
Randi Hernandez
In this article, industry experts discuss critical analyses for demonstrating biosimilarity. / read more /
|
|
FORMULATION
Adeline Siew, PhD
Emerging controlled-release technologies could lead to more effective therapies in the near future.
/ read more /
|
|
|
PharmTech Europe April Issue
|
|
advertisement
|
|
|
|
PEER-REVIEWED RESEARCH
James Agalloco
The Human Microbiome Project has increased our understanding of the relationship between humans and microorganisms. The authors offer a new perspective on how this knowledge should be considered in setting standards for pharmaceutical quality control in microbiology.
/ read more /
|
|
|
API SYNTHESIS & MANUFACTURING
Cynthia A. Challener
New legislation and changes in policy at FDA are leading to better control of the API supply chain.
/ read more /
|
|
|
TROUBLESHOOTING
Katriona Scoffin
Efficient freeze-drying processes result in time and energy savings, reduced failure rates, and improved batch consistency.
/ read more /
|
|
|
OUTSOURCING REVIEW
Jim Miller
Big service providers get bigger faster thanks to Big Pharma.
/ read more /
|
|
|
REGULATORY WATCH
Sean Milmo
Drug developers understand the importance of early communication with regulators, but is EMA providing enough flexibility and support to companies?
/ read more /
|
|
|
EMERGING MARKET REPORT
Jane Wan
Hope abounds for local drug discovery companies despite challenges at home.
/ read more /
|
|
|
OTHER FEATURES
Hallie Forcinio
Industry awaits the final revision of USP General Chapter <1207> and the impact it will have on the evaluation of sterile product package integrity.
/ read more /
Faiz Kermani
As the prevalence of falsified medicines continues to increase, Switzerland is taking measures to secure its supply chain such as the implementation of serialization.
/ read more /
Adeline Siew, PhD
A review of some of the latest packaging and drug-delivery innovation presented at Pharmapack Europe.
/ read more /
|
|
|
Webcasts
Thursday, May 14, 2015, 11 am EDT/8 am PDT/16:00 BST/17:00 CEST
Join this informative webinar, presented by the team at Eurofins Lancaster Laboratories, to learn about the various aspects of cell banking and cell line characterization, including GMP production master and working cell banks, GMP non-production (e.g. bioassay) master and working cell banks, R&D cell banks or banking for end of production cells.
Sponsored by: Eurofins Lancaster Laboratories
Register Free
On Demand
API process validation experts describe the different activities required during the process design and process qualification stages, as well as continued process verification throughout the life of the commercial process. Hear about key requirements for API process validation including regulatory requirements, manufacturing conditions, data collection, testing to be performed, sampling plans, and analytical method validation. Sponsored by: Regis Technologies Inc.
more webcasts
|
|
|
|
Events
April 21 - 23, 2015 | New York
April 23-24, 2015 | London, England
May 05-08, 2015 | Antibes, France
more events
|
|
|
|
|